Merck is an A+ credit, a global oncology powerhouse, and still, about half its 2024 pharma revenue came from a…
News round-up for 8 – 12 December by Bruno Quinney, Content Team at DDW. This week in DDW, innovative treatments have…
Sign in to your account
Remember me
